Disorders and Treatment
- Mental Illness
- Bipolar Disorder
- Mood Disorders
- Borderline Personality
- Mental Health Diagnosis
- Mental Health Treatments
- Alternative Meds
- Case Studies
For women who experience severe depression during pregnancy, the options for treating the condition seem few. It has long been believed that taking any kind of antidepressant could cause significant harm, even death, to the baby.
However, a recent study found that pregnant women taking selective serotonin reuptake inhibitors (SSRIs) did not have an increased risk of still birth or infant mortality.
“Depression during pregnancy is common with prevalences ranging between 7% and 19% in economically developed countries,” according to the report published in JAMA. “Maternal depression is associated with poorer pregnancy outcomes, including increased risk of preterm delivery, which in turn may cause neonatal morbidity and mortality.”
There are still consequences to taking the drugs: “Use of selective serotonin reuptake inhibitors during pregnancy has been associated with congenital anomalies, neonatal withdrawal syndrome, and persistent pulmonary hypertension of the newborn. However, the risk of stillbirth and infant mortality when accounting for previous maternal psychiatric disease remains unknown.” Other side effects for the baby include post-birth withdrawal from the SSRIs and high blood pressure in the lungs.
Researchers reviewed singleton births from 1996 to 2007. They cross-referenced prescription registries to see who was taking SSRIs. They adjusted results for variables including maternal characteristics and prior hospitalization for mental illness. The stillbirth and postneonatal deaths were no different between women on SSRIs and women who were significantly mentally ill. The drug did not cause the deaths.
“The present study of more than 1.6 million births suggests that SSRI use during pregnancy was not associated with increased risk of stillbirth, neonatal death, or postneonatal death. The increased rates of stillbirth and postneonatal mortality among infants exposed to an SSRI during pregnancy were explained by the severity of the underlying maternal psychiatric disease and unfavorable distribution of maternal characteristics such as cigarette smoking and advanced maternal age,” the report states.
Source: JAMA, MedicalNewsToday
The information provided on the PsyWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her health professional. This information is solely for informational and educational purposes. The publication of this information does not constitute the practice of medicine, and this information does not replace the advice of your physician or other health care provider. Neither the owners or employees of PsyWeb.com nor the author(s) of site content take responsibility for any possible consequences from any treatment, procedure, exercise, dietary modification, action or application of medication which results from reading this site. Always speak with your primary health care provider before engaging in any form of self treatment. Please see our Legal Statement for further information.